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Abstract 
Upon completition of human genome project, there has been a huge effort to identify genes that have been associated 
to mental disorders like schizophrenia or depression.  However, these investigations still remain at theoretical level. 
Thus, psychiatry does not seem to benefit from postgenomic era as desired. This paper will briefly discuss the reasons 
for this bottleneck in terms of the complexity of mental disorders.  
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1. Introduction 
Mental disorders are brain diseases that arise from the 
complex interplay of nature and nurture. In comparison 
to other complex disorders however, the effect of nature 
appears to be quite strong: the susceptibility for major 
psychiatric disorders show a strong degree of heritability 
(Moldin and Gottesman, 1997). Thus, following the 
completition of human genome project (HGP), there has 
been a huge effort to identify genes that have been 
associated to mental disorders like schizophrenia or 
depression. However, these investigations still remain at 
theoretical level.  
 
This problem is already well reflected in the lack of 
validated drug targets.  For example, a careful 
observation of scientific studies between the years of 
1990-2001 will show the dramatic increase in the total 
number of research papers related to cognition and 
schizophrenia but, this progress was not translated to 
drug research as the clinical trials during the same 
period remained unchanged (Hyman and Fenton, 2003). 
Thus, considering the potential of new genetic 
approaches (see below), psychiatry does not seem to 
benefit from postgenomic era as desired. This paper will 
briefly discuss the reasons for this problem in terms of 
the complexity of mental disorders. 
 
2. The Human genome project and new opportunities  
 
The completition of Human Genome Project (HGP) in 
2001 has had big impact in the society both 
economically and medically. According to a study 
published by Battelle Technology Partnership Practice 
(2011), $3.8 billion investment on the HGP by the US 
government has led to a drive of $796 billion in the U.S. 
economy between the years 1998-2003. Besides, 
medical diagnosis, treatment and disease prevention 
have been innovated. For instance, EGFR mutation in 
lung cancer, KRAS mutation in colon and lung cancers, 
BRAF mutation in colon cancer have led to the 
identification of molecular markers to be used for 
diagnosis (McLeod, 2013).  
 
Although genomic approaches increasingly provide new 
answers in medical practice, much basic research 
remains to be done for an effective application of 
genomics especially for a translational psychiatric 
research. The HGP has led to the emergence of new 
approaches for the utilization of new genetic data. 
Among these approaches, analysis of genetic variations, 
i.e., single nucleotide polymorphisms (SNPs), analysis 
of gene expression and gene function have been 
especially powerful (Tang et al., 2009). As a result of 
these methodologies many candidate genes have been 
identified in relation to mental disorders like 
schizophrenia or depression but these investigations still 
remain at theoretical level (Ptacek et al., 2011). Why 
does not psychiatry seem to benefit from genomic 
revolution as desired ? This problem is likely a factor of 
complex nature of psychiatric diseases. 
 
3. Genotype, phenotype and environment  
 
Mental disorders are not caused by a single gene, rather 
by multiple genes (Arslan, 2015). The multiple genetic 
factors will not be discussed here in detail as it is rather 
a better known phenomenon. The genetic complexity of 
mental disorders is further increased by 
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gene×environment (G×E) interactions in between the 
genotype and phenotype (Caspi and Moffitt, 2006). 
Regarding this, a good example comes from a study of 
2002 by Caspi et al. who published a research paper 
showing the role of the monoamine oxidase A gene 
(MAOA) in the development of antisocial behaviors. 
Utilizing the data from the Dunedin Multidisciplinary 
Health and Development Study (DMHDS), Caspi et al. 
showed the effect of G×E interactions between 
childhood maltreatment and the variations in the MAOA 
gene in the development of antisocial behaviors. Thus, 
the associations between childhood maltreatment and 
antisocial behavior have been found to be modified by 
the variations of MAOA gene. The gene encodes the 
Monoamine oxidase A (MAOA), an enyzme, which 
catalyzes the oxidative deamination of biogenic amines, 
including serotonin (5-HT), norepinephrine (NE), and 
dopamine (DA) and the neuromodulator phenyl 
ethylamine (PEA). There are several variations in the 
MAOA gene and these polymorphisms have already 
been shown to be associated with behavioral phenotypes 
such as aggression and substance abuse besides to 
affective disorders like bipolar disorder and panic 
disorder (reviewed in Shih and Thompson, 1999). 
Among these variations, a well-characterized upstream 
variable number tandem repeat (uVNTR) polymorphism 
in the promoter region of the MAOA gene that is known 
to affect gene expression causing high activity or low 
activity MAOA variants. Caspi et al (2002) found that 
the carriers of the low activity variant are more 
responsive to the effects of childhood maltreatment 
associated with the development of antisocial 
personality disorder than the carriers of high-activity 
variant. Since then, this paper has been well replicated 
Enoch et al., 2010 Prom et al., 2009Sjoberg 2007, 
Nilsson et al/. 2006 despite some negative results 
(Huang et al., 2004). Nevertheless the results were 
further supported by a study of meta-analysis (Taylor 
and Kim-Cohen, 2007). While the effect of the GxE is 
evident, it remains unclear how to incorporate this 
parameter in to genetic analysis as multiple genetic 
variations needs to be assessed in terms of 
environmental factors. 
 
Besides to the complexity of genetic factors, and gene-
environment interactions, a further complexity is the 
lack of biologically defined diagnostic criteria: 
psychiatric disorders are diagnosed on clinical grounds. 
According to the current version of the Diagnostic and 
Statistical Manual of Mental Disorders-V, (DSM-V), 
there are over 300 different types of mental disorders. 
One problem is the problem of objectivity:  the main 
source of information about the symptoms come from 
the patients so they may not be objective. Still, many 
psychiatric illnesses can be diagnosed reliably according 
to the Diagnostic and Statistical Manual (DSM) and the 
International Classification of Diseases (ICD) the 
standard diagnostic guidelines. But these guidelines 
often does not provide the objective tests to draw 
boundaries around a particular clinical state (Tandon 
2012). Another problem is that sometimes patients may 
show a combination of such phenotypes (symptoms) that 
overlap across these disease boundaries defined by DSM 
(Arslan, 2015). Since the classical psychiatric genetic 
research has been directed to genetic effects on disease, 
it is likely that gene-discovery studies in psychiatric 
research still remains at the theoretical level, because 
disease diagnosis is not based on biological criteria so it 
interferes with the top-down research (Arslan, 2015).  
4. Conclusion 
 
Despite the opportunities of genomic revolution, there is 
a lack of genetic markers that reliably guide the 
diagnosis of psychiatric disorders (Hyman and Fenton, 
2003). This problem seems to derive from the complex 
nature of psychiatric disorders. These complexities are 
multiple genetic factors, gene-environment interactions, 
subjective nature of psychiatric phenotypes and the lack 
of biologically defined diagnostic criteria that interferes 
with the top-down research. Recognition of these 
complexities however will lead to the emergence of new 
approaches. Among these approaches, integration of 
environmental factors into functional neuroimaging 
studies have good implications (Lederbogen, F., et al., 
2011; Meyer-Lindenberg and Tost, 2012). Moreover, 
there is a growing literature addressing the complexity 
problem of psychiatric phenotypes by the use of 
intermediate phenotypes since 2000s (Bookheimer, et 
al., 2000).  With the support of new statistical 
developments, a further progress  will be the 
accumulation of data collected by multivariate, large-
scale analysis of genetics and intermediate phenotypes 
that eventually leads to the analysis of psychiatric 
phenomenon in terms of neural activity, genetic 
variation, environmental context together.  
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